Autolus Therapeutics plc (AUTL) Stock price, Description, News & Info

#ThinkSabio Latest News

Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)